News

Roche announced that Venclexta (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for…
Read More...

Takeda Pharmaceutical Company Limited announced an additional agreement with Moderna and the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) to import and distribute…
Read More...

Relmada Therapeutics, Inc. a late-stage biotechnology company addressing diseases of the central nervous system (CNS), announced the acquisition of development and commercial rights to…
Read More...

BioNTech SE und Kite, a Gilead Company announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR)…
Read More...

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has granted Fast…
Read More...

RxCelerate, a leading international out-sourced drug discovery and development platform, announced that it has established a venture capital fund, RxCapital, to invest in companies…
Read More...

Roche announced results from the final analysis of the phase IIIb STASEY study, which confirm the favourable safety profile of Hemlibra (emicizumab), consistent with the phase III HAVEN…
Read More...

AstraZeneca’s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with…
Read More...

LabGenius, a pioneer in the use of machine learning (ML) for protein engineering, today announced the signing of a multi-year research collaboration with Ablynx, a Sanofi company.…
Read More...

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity…
Read More...

Kintor Pharmaceutical Limited announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. ("Fosun Pharma Development"), on the…
Read More...

Ocugen, Inc. a biopharmaceutical company focused on discovering, developing and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from…
Read More...

Eli Lilly and Company and Banner Alzheimer's Institute announced a strategic research collaboration as part of the planned Phase 3, randomized, placebo-controlled study evaluating…
Read More...

GentiBio, Inc., an emerging biotherapeutics company developing best-in-class engineered regulatory T cells programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic…
Read More...

Thermo Fisher Scientific Inc. the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced it has entered into a definitive agreement to acquire LakePharma Inc., a…
Read More...

MediPharm Labs Corp. a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, is pleased to announce it has received…
Read More...

Medable Inc., the leading cloud platform for patient-centered drug development, announced the first stage of its European expansion plans with a new EMEA headquarters in Dublin. The…
Read More...

Eli Lilly and Company announced the acquisition of Protomer Technologies ("Protomer"), a private biotech company. Protomer's proprietary peptide- and protein-engineering platform is…
Read More...

Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, announced the closing of a $100 Million Series B financing…
Read More...